Apple Health (Medicaid) drug coverage criteria

Use this page to find drug policies and request forms.

For information on billing and rates, the Apple Health preferred drug list, and expedited authorization codes, please visit the Prescription Drug Program on our provider billing guide and rates page.

Coverage for	Policies	Policy Number
Androgenic Agents	Testosterone Replacement Therapy (TRT)	23.10.00
Antiasthmatic Monoclonal Antibodies	Anti-IgE antibodies IL-5 antagonists	44.60.30 44.60.40
Antibiotics	Anti-infective agents - Rifaximin Inhaled aminoglycosides Inhaled Aztreonam	16.00.00.49 07.00.00 16.14.00
Antidiabetics	Amylin analogs	27.15.00
Antihyperlipidemics	Apolipoprotein B (APOB) synthesis inhibitors - Lomitapide Mesylate PCSK-9 inhibitors	39.48.00 39.35.00
Antiparasitics	Antiprotozoal agents – Nitazoxanide	16.40.00.60
Antivirals	Hepatitis C treatments	12.35.30.99
Atopic Dermatitis Agents	Dupilumab Topical immunosuppressives	90.27.30.20 90.78.40
Bone Density Regulators	Bone Density Regulators	30.04.00
Brands with Generic Equivalents	Brands with generic equivalents	NC-001
Cardiovascular Agents	Sinus node inhibitors Valsartan-Sacubitril	40.70.00 40.99.20
Chronic GI Motility Agents	Chronic GI motility agents	52.55.00
Cytokine and CAM Agents	Cytokine and CAM agents	66.27.00
Endocrine and Metabolic Agents: Metabolic Modifiers	Phenylketonuria (PKU) agents - Pegvaliase-pqpz Phenylketonuria (PKU) agents - Sapropterin Tripeptidyl Peptidase 1 Deficiency agents - Cerliponase Alfa X-Linked Hypohosphatemia (XLH) agents - Burosumab--twza	30.90.85.50 30.90.85.65 30.90.90 30.90.95
Growth Hormone Agents	Growth Hormone Agents	30.10.00
Hematopoietic Agents	Erythropoiesis-stimulating agents (ESAs) Granulocyte colony stimulating factors (G-CSF) Thrombopoiesis (TPO) stimulating proteins	82.40.10 82.40.15 82.40.50
Migraine Products	Calcionin gene-related peptide (CGRP) receptor antagonists	67.70.20
Medication Treatment for Substance Abuse Disorders (SUDs)	Buprenorphine containing products Request for Buprenorphine Monotherapy (13-330) Naltrexone containing products	65.20.00.10 93.40.00.20
Methadone	Methadone	65.10.00.50
Opioids	Opioid Clinical Policy	65.10.00
Ophthalmics	Immunomodulators	86.73.40
Progesterones	Hydroxyprogesterone Caproate	26.00.00
Proton Pump Inhibitors (PPIs)	Proton Pump Inhibitor (PPI) Policy	49.27.00
Psychotherapeutic and Neurological Agents – MISC : Multiple Sclerosis Agents	Dalfampridine Ocrelizumab	62.40.60.30 62.40.50.60
Psychotherapeutic and Neurological Agents – MISC : Transthyretin Amyloidosis Agents	Transthyretin Amyloidosis Agents	62.70.00
Pulmonary Arterial Hypertension (PAH) Agents	Pulmonary Arterial Hypertension (PAH) Agents	40.12.00
Pulmonary Fibrosis Agents	Pulmonary Fibrosis Agents	45.55.00
Respiratory Agents – MISC	Alpha-Proteinase Inhibitor (Human)	45.10.00.00
Spinraza	Spinraza Policy	74.70.00
Transmucosal Fentanyl Products	Transmucosal Fentanyl Products	65.10.00.25